Carbonic Anhydrase Inhibitors in the Treatment of Glaucoma. Review. Part II

Topical and systemic carbonic anhydrase inhibitors (CAIs) are widely used in the treatment of glaucoma for reducing intraocular pressure. This part of the review describes the characteristics of systemic CAIs, their side effects and the ways to overcome them, as well as contraindications. The use of...

Full description

Bibliographic Details
Main Author: N. I. Kurysheva
Format: Article
Language:Russian
Published: Ophthalmology Publishing Group 2020-12-01
Series:Oftalʹmologiâ
Subjects:
Online Access:https://www.ophthalmojournal.com/opht/article/view/1357